Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Cosmetics News & Events

Cosmetics News & Events

                        Meetings, Conferences & Workshops on Cosmetics Home
          Cosmetics
          Cosmetics News & Events
          Public Meeting on Testing Methods for Asbestos in Talc and Cosmetic Products Containing Talc - 02/04/2020Cosmetics News & Events Meeting
    Event Title
              Public Meeting on Testing Methods for Asbestos in Talc and Cosmetic Products Containing Talc


                  February 4, 2020

  

    
  Share
    Post
    Linkedin

    Email
    PrintDate:
          
  


     
           

February 4, 2020   

 
 
        
                                      Time: 
                                      
8:30 AM
    - 5:00 PM
ET

 





What's New

January 13, 2022

FDA announces the release of a white paper and technical appendices on testing methods for asbestos in cosmetic products containing talc.

Constituent Update: FDA Releases White Paper on Testing Methods for Asbestos in Cosmetic Products Containing Talc
	FDA News Release: FDA Releases Federal Interagency Working Group Scientific Opinions on Testing Methods for Asbestos in Talc-Containing Cosmetic Products
	IWGACP Scientific Opinions  on Testing Methods for Asbestos in Cosmetic Products Containing Talc (including Talc Intended for Use in Cosmetics)


FDA held a public meeting on testing methods for asbestos in talc and cosmetic products containing talc on February 4, 2020 at the FDA White Oak Campus (10903 New Hampshire Ave, The Great Room, Building 31, Silver Spring, Md. 20993).

The purpose of the public meeting was to discuss and obtain scientific data and information on topics related to testing methodologies, terminology, and criteria that can be applied to characterize and measure asbestos and other potentially harmful elongate mineral particles (EMPs) that may be present as contaminants in talc and consumer products, including cosmetics, containing talc as an ingredient.

The meeting included discussions of key topics, such as:

a federal interagency working group’s preliminary recommendations related to terminology and definitions of asbestos and other EMPs of health concern; and
	scientific data and information related to methodologies, terminology and criteria that can be used in the development of standardized testing methods to improve sensitivity, consistency, and inter-laboratory concurrence of asbestos testing.Recordings & Transcript

Recording Part0
	Recording Part1
	Recording Part2
	Recording Part3
	Full Meeting Transcript (PDF: 7.33MB)Commenting

You may view electronically submitted comments on https://www.regulations.gov/ in docket folder FDA-2020-N-0025.

Additional Information

Federal Register Notice Announcing the Public Meeting
	Federal Register Notice: Availability of FDA Statement Added to the Docket for Public Meeting Related to Cosmetic Products Containing Talc
	FDA Statement
	FDA’s Talc webpage





Event Materials

  Title
            File Type/SizeExecutive Summary: Preliminary Recommendations on Testing Methods for Asbestos in Talc and Consumer Products Containing Talc
              pdf               (106.23 KB)Biographies: Testing Methods for Asbestos in Talc and Cosmetic Products Containing Talc Public Meeting Speakers and Panelists
              pdf               (127.88 KB)Agenda: Testing Methods for Asbestos in Talc and Cosmetic Products Containing Talc Public Meeting
              pdf               (183.70 KB)Speaker Presentation: Overview of Issues for Talc-Containing Cosmetic Products by Linda M. Katz, M.D., M.P.H. from FDA (February 4, 2020)
              pptx               (1.46 MB)Speaker Presentation: Wrap-up and Next Steps by Linda M. Katz, M.D, M.P.H. from FDA (February 4, 2020)
              pptx               (1.42 MB)Speaker Presentation: Interagency Working Group on Asbestos in Consumer Products (IWGACP) Overview by Deborah C. Smegal, M.P.H. from FDA (February 4, 2020)
              pptx               (625.34 KB)Speaker Presentation: Recommendations from the IWGACP - Terminology and Definitions of Mineral Fibers of Concern in Talc by Paul C. Howard, Ph.D. from FDA (February 4, 2020)
              pptx               (3.48 MB)Speaker Presentation: Recommendations from the IWGACP - Analytical  Methods for Detecting Mineral Fibers of Concern in Talc and Talc-Containing Consumer Products by Paul C. Howard, Ph.D. from FDA (February 4, 2020)
              pptx               (4.38 MB)Speaker Presentation: Recommendations from the IWGACP - Content and Format of Analytical Reports, and Recap of Overall Preliminary Recommendations by Steven M. Wolfgang, Ph.D. from FDA (February 4, 2020)
              pptx               (6.88 MB)Speaker Presentation: Mineral Fibers in the Lung - Exposure and Toxicity by Christopher P. Weis, Ph.D., D.A.B.T. from the National Institute of Environmental Health Sciences (February 4, 2020)
              pptx               (5.69 MB)Talc Public Meeting Commenter Presentation: Andre Nel, University of California, Los Angeles (February 4, 2020)
              pdf               (71.88 KB)Talc Public Meeting Commenter Presentation: Bryan Bandli, RJ Lee Group (February 4, 2020)
              pdf               (2.27 MB)Talc Public Meeting Commenter Presentation: David Egilman, Never Again Consulting (February 4, 2020)
              pptx               (6.66 MB)Talc Public Meeting Commenter Presentation: Diana Zuckerman, National Center for Health Research (February 4, 2020)
              pptx               (2.32 MB)Talc Public Meeting Commenter Presentation: Eric Chatfield, Chatfield Technical Consulting Limited (February 4, 2020)
              pptx               (233.69 KB)Talc Public Meeting Commenter Presentation: Frank Ehrenfeld, International Asbestos Testing Laboratories (February 4, 2020)
              pptx               (1.37 MB)Talc Public Meeting Commenter Presentation: Jeniffer Carson, CmBG3 Law LLC (February 4, 2020)
              pptx               (132.54 KB)Talc Public Meeting Commenter Presentation: John Godleski, John J. Godleski MD PLLC (February 4, 2020)
              pptx               (21.23 MB)Talc Public Meeting Commenter Presentation: Laura Plunkett, Integrative Biostrategies LLC (February 4, 2020)
              pptx               (678.70 KB)Talc Public Meeting Commenter Presentation: Leigh O’Dell, Beasley Allen Law Firm (February 4, 2020)
              pptx               (2.90 MB)Talc Public Meeting Commenter Presentation: Mark Ellis, Industrial Minerals Association (February 4, 2020)
              pdf               (1.28 MB)Talc Public Meeting Commenter Presentation: Mickey Gunter, University of Idaho (February 4, 2020)
              pptx               (14.26 MB)Talc Public Meeting Commenter Presentation: Robyn Ray, EMSL Analytical Inc (February 4, 2020)
              ms-powerpoint               (12.30 MB)Talc Public Meeting Commenter Presentation: Scott Faber, Environmental Working Group (February 4, 2020)
              pptx               (13.10 MB)Talc Public Meeting Commenter Presentation: Sean Fitzgerald, Scientific Analytical Institute (February 4, 2020)
              pdf               (16.84 MB)Talc Public Meeting Commenter Presentation: Steven Compton, MVA Scientific Consultant (February 4, 2020)
              pptx               (9.49 MB)Talc Public Meeting Commenter Presentation: William Longo, MAS LLC (February 4, 2020)
              pdf               (2.12 MB)Speaker Presentation: Mineral Fibers of Potential Concern in Talc - Geology and Mineralogy by Bradley S. Van Gosen from the United States Geological Survey (February 4, 2020)
              pdf               (12.72 MB)Transcript of the Public Meeting on Testing Methods for Asbestos in Talc and Cosmetic Products Containing Talc - 02/04/2020 - 02/04/2020
              pdf               (7.33 MB)

                                                                                  Content current as of:
      02/25/2022
         
                   
Regulated Product(s)
		 CosmeticsMore Meetings,
      Conferences, and
      Workshops
        
        Cosmetics News & Events

          
                        Meetings, Conferences & Workshops on Cosmetics
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop